Cited by 311

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins

Vallejo, Luis Felipe, Rinas, Ursula·2004·Microbial Cell Factories

Abstract

Recent advances in generating active proteins through refolding of bacterial inclusion body proteins are summarized in conjunction with a short overview on inclusion body isolation and solubilization procedures. In particular, the pros and cons of well-established robust refolding techniques such as direct dilution as well as less common ones such as diafiltration or chromatographic processes including size exclusion chromatography, matrix- or affinity-based techniques and hydrophobic interaction chromatography are discussed. Moreover, the effect of physical variables (temperature and pressure) as well as the presence of buffer additives on the refolding process is elucidated. In particular, the impact of protein stabilizing or destabilizing low- and high-molecular weight additives as well as micellar and liposomal systems on protein refolding is illustrated. Also, techniques mimicking the principles encountered during in vivo folding such as processes based on natural and artificial chaperones and propeptide-assisted protein refolding are presented. Moreover, the special requirements for the generation of disulfide bonded proteins and the specific problems and solutions, which arise during process integration are discussed. Finally, the different strategies are examined regarding their applicability for large-scale production processes or high-throughput screening procedures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1475-2859-3-11

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 155

  1. Carrió MM, Villaverde A: Protein aggregation as bacterial inclusion bodies is reversible. FEBS Lett. 2001, 489: 29-33. 10.1016/S0014-5793(01)02073-7. · DOI
  2. Datar RV, Cartwright T, Rosen C-G: Process economics of animal cell and bacterial fermentations: A case study analysis of tissue plasminogen activator. Bio/Technology. 1993, 11: 349-357. 10.1038/nbt0393-349. · DOI
  3. Qiu J, Swartz JR, Georgiou G: Expression of active human tissue-type plasminogen activator in Escherichia coli. Appl Environ Microbiol. 1998, 64: 4891-4896. · DOI
  4. Zhan X, Schwaller M, Gilbert HF, Georgiou G: Facilitating the formation of disulfide bonds in the Escherichia coli periplasm via coexpression of yeast protein disulfide isomerase. Biotechnol Prog. 1999, 15: 1033-1038. 10.1021/bp990083r. · DOI
  5. Schäffner J, Winter J, Rudolph R, Schwarz E: Cosecretion of chaperones and low-molecular-size medium additives increases the yield of recombinant disulfide-bridged proteins. Appl Environ Microbiol. 2001, 67: 3994-400. 10.1128/AEM.67.9.3994-4000.2001. · DOI
  6. Manosroi J, Tayapiwatana C, Götz F, Werner RG, Manosroi A: Secretion of active recombinant human tissue plasminogen activator derivatives in Escherichia coli. Appl Environ Microbiol. 2001, 67: 2657-2664. 10.1128/AEM.67.6.2657-2664.2001. · DOI
  7. Manosroi J, Tayapiwatana C, Manosroi A, Beer J, Bergemann K, Werner RG: Lekteplase – a secreted tissue plasminogen activator derivative from Escherichia coli. Arzneim-Forsch. 2002, 52: 60-66.
  8. Martegani E, Forlani N, Mauri I, Porro D, Schleuning WD, Alberghina L: Expression of high levels of human tissue plasminogen activator in yeast under the control of an inducible GAL promoter. Appl Microbiol Biotechnol. 1992, 37: 604-608. 10.1007/BF00240734. · DOI
  9. Wiebe MG, Karandikar A, Robson GD, Trinci APJ, Flores Candia J-L, Trappe S, Wallis G, Rinas U, Derkx PMF, Madrid SM, Sisniega H, Faus I, Montijn R, van den Hondel CAMJJ, Punt PJ: Production of tissue plasminogen activator (t-PA) in Aspergillus niger. Biotechnol Bioeng. 2001, 76: 164-174. 10.1002/bit.1156. · DOI
  10. Farrell PJ, Behie LA, Iatrou K: Transformed lepidopteran insect cells: New sources of recombinant human tissue plasminogen activator. Biotechnol Bioeng. 1999, 64: 426-433. 10.1002/(SICI)1097-0290(19990820)64:4<426::AID-BIT5>3.3.CO;2-R. · DOI
  11. Lilie H, Schwarz E, Rudolph R: Advances in refolding of proteins produced in E. coli. Curr Opin Biotechnol. 1998, 9: 497-501. 10.1016/S0958-1669(98)80035-9. · DOI
  12. De Bernardez Clark E: Refolding of recombinant proteins. Curr Opin Biotechnol. 1998, 9: 157-163. 10.1016/S0958-1669(98)80109-2. · DOI
  13. Gergiou G, Valax P: Isolating inclusion bodies from bacteria. Methods Enzymol. 1999, 309: 48-58. · DOI
  14. De Bernardez Clark E, Schwarz E, Rudolph R: Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol. 1999, 309: 217-236. · DOI
  15. De Bernardez Clark E: Protein refolding for industrial processes. Curr Opin Biotechnol. 2001, 12: 202-207. 10.1016/S0958-1669(00)00200-7. · DOI
  16. Middelberg APJ: Preparative protein refolding. Trends Biotechnol. 2002, 20: 437-443. 10.1016/S0167-7799(02)02047-4. · DOI
  17. Tsumoto K, Ejima D, Kumagai I, Arakawa T: Practical considerations in refolding proteins from inclusion bodies. Protein Expr Purif. 2003, 28: 1-8. 10.1016/S1046-5928(02)00641-1. · DOI
  18. Fahnert B, Lilie H, Neubauer P: Inclusion bodies: Formation and utilization. Adv Biochem Eng/Biotechnol. 2004, 89: 93-142.
  19. Rinas U, Bailey JE: Protein compositional analysis of inclusion bodies produced in recombinant Escherichia coli. Appl Microbiol Biotechnol. 1992, 37: 609-614. 10.1007/BF00240735. · DOI
  20. Hagel P, Gerding JJT, Fieggen W, Bloemendal H: Cyanate formation in solutions of urea I. Calculation of cyanate concentrations at different temperature and pH. Biochim Biophys Acta. 1971, 243: 366-373. 10.1016/0005-2795(71)90003-1. · DOI
  21. Cejka J, Vodražka Z, Salák J: Carbamylation of globin in electrophoresis and chromatography in the presence of urea. Biochim Biophys Acta. 1968, 154: 589-591. 10.1016/0005-2795(68)90021-4. · DOI
  22. Estapé D, Rinas U: Optimized procedures for purification and solubilization of basic fibroblast growth factor inclusion bodies. Biotechnol Tech. 1996, 10: 481-484. · DOI
  23. Iwakura M, Obara K, Kokubu T, Ohashi S, Izutsu H: Expression and purification of growth hormone-releasing factor with the aid of dihydrofolate reductase handle. J Biochem (Tokyo). 1992, 112: 57-62. · DOI
  24. Khan RH, Appa Rao KBC, Eshwari ANS, Totey SM, Panda AK: Solubilization of recombinant ovine growth hormone with retention of native-like secondary structure and its refolding from the inclusion bodies of Escherichia coli. Biotechnol Prog. 1998, 14: 722-728. 10.1021/bp980071q. · DOI
  25. Patra AK, Mukhopadhyay R, Mukhija R, Krishnan A, Garg LC, Panda AK: Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Protein Expr Purif. 2000, 18: 182-192. 10.1006/prep.1999.1179. · DOI
  26. Thatcher DR, Hitchcock A: Protein folding in biotechnology. In Mechanisms of protein refolding. Edited by: Pain HR. 1994, Oxford: Oxford University Press, 229-254. · DOI
  27. Puri NK, Crivelli E, Cardamone M, Fiddes R, Bertolini J, Ninham B, Brandon MR: Solubilization of growth hormone and other recombinant proteins from Escherichia coli by using a cationic surfactant. Biochem J. 1992, 285: 871-879. · DOI
  28. Kurucz I, Titus JA, Jost CR, Segal DM: Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies. Mol Immunol. 1995, 32: 1443-1452. 10.1016/0161-5890(95)00105-0. · DOI
  29. Tsumoto K, Umetsu M, Kumagai I, Ejima D, Arakawa T: Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine. Biochem Biophys Res Commun. 2003, 312: 1383-1386. 10.1016/j.bbrc.2003.11.055. · DOI
  30. Umetsu M, Tsumoto K, Ashish K, Nitta S, Tanaka Y, Adschiri T, Kumagai I: Structural characteristics and refolding of in vivo aggregated hyperthermophilic archaeon proteins. FEBS Lett. 2004, 557: 49-56. 10.1016/S0014-5793(03)01441-8. · DOI
  31. Tokatlidis K, Dhurjati P, Millet J, Béguin P, Aubert J-P: High activity of inclusion bodies formed in Escherichia coli overproducing Clostridium thermocellum endoglucanase D. FEBS Lett. 1991, 282: 205-208. 10.1016/0014-5793(91)80478-L. · DOI
  32. Zettlmeissl G, Rudolph R, Jaenicke R: Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation. Biochemistry. 1979, 18: 5567-5575. · DOI
  33. Kiefhaber T, Rudolph R, Kohler H-H, Buchner J: Protein aggregation in vitro and in vivo: A quantitative model of the kinetic competition between folding and aggregation. Bio/Technology. 1991, 9: 825-829. 10.1038/nbt0991-825. · DOI
  34. Goldberg ME, Rudolph R, Jaenicke R: A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry. 1991, 30: 2790-2797. · DOI
  35. De Bernardez Clark E, Hevehan D, Szela S, Maachupalli-Reddy J: Oxidative renaturation of hen egg-white lysozyme. Folding vs aggregation. Biotechnol Prog. 1998, 14: 47-54. 10.1021/bp970123w. · DOI
  36. Tran-Moseman A, Schauer N, De Bernardez Clark E: Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor. Protein Expr Purif. 1999, 16: 181-189. 10.1006/prep.1999.1074. · DOI
  37. Katoh S, Katoh Y: Continous refolding of lysozyme with fed-batch addition of denatured protein solution. Process Biochem. 2000, 35: 1119-1124. 10.1016/S0032-9592(00)00145-X. · DOI
  38. Gu Z, Su Z, Janson J-C: Urea gradient size-exclusion chromatography enhanced the yield of lysozyme refolding. J Chromatogr A. 2001, 918: 311-318. 10.1016/S0021-9673(01)00766-X. · DOI
  39. Tikhonov RV, Pechenov SE, Belacheu IA, Yakimov SA, Klyushnichenko VE, Tunes H, Thiemann JE, Vilela L, Wulfson AN: Recombinant human insulin IX. Investigation of factors, influencing the folding of fusion protein-S-sulfonates, biotechnological precursors of human insulin. Protein Express Purif. 2002, 26: 187-193. 10.1016/S1046-5928(02)00531-4. · DOI
  40. Vallejo LF, Rinas U: Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration. Biotechnol Bioeng. 2004, 85: 601-609. 10.1002/bit.10906. · DOI
  41. Ho JGS, Middelberg APJ, Ramage P, Kocher HP: The likelihood of aggregation during protein renaturation can be assessed using the second virial coefficient. Protein Sci. 2003, 12: 708-716. 10.1110/ps.0233703. · DOI
  42. Maachupalli-Reddy J, Kelley BD, De Bernardez Clark E: Effect of inclusion body contaminants on the oxidative renaturation of hen egg white lysozyme. Biotechnol Prog. 1997, 13: 144-150. 10.1021/bp970008l. · DOI
  43. Batas B, Schiraldi C, Chaudhuri JB: Inclusion body purification and protein refolding using microfiltration and size exclusion chromatography. J Biotechnol. 1999, 68: 149-158. 10.1016/S0168-1656(98)00197-7. · DOI
  44. Müller C, Rinas U: Renaturation of heterodimeric platelet-derived growth factor from inclusion bodies of recombinant Escherichia coli using size-exclusion chromatography. J Chromatogr A. 1999, 855: 203-213. 10.1016/S0021-9673(99)00660-3. · DOI
  45. Buchner J, Pastan I, Brinkmann U: A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal Biochem. 1992, 205: 263-270. · DOI
  46. Fischer B, Perry B, Sumner I, Goodenough P: A novel sequential procedure to enhance the renaturation of recombinant protein from Escherichia coli inclusion bodies. Protein Eng. 1992, 5: 593-596. · DOI
  47. Terashima M, Suzuki K, Katoh S: Effective refolding of fully reduced lysozyme with a flow-type reactor. Process Biochem. 1996, 31: 341-345. 10.1016/0032-9592(95)00069-0. · DOI
  48. Maeda Y, Koga H, Yamada H, Ueda T, Imoto T: Effective renaturation of reduced lysozyme by gentle removal of urea. Protein Eng. 1995, 8: 201-205. · DOI
  49. Varnerin JP, Smith T, Rosenblum CI, Vongs A, Murphy BA, Nunes C, Mellin TN, King JJ, Burgess BW, Junker B, Chou M, Hey P, Frazier E, MacIntyre DE, van der Ploeg LHT, Tota MR: Production of leptin in Escherichia coli: A comparison of methods. Protein Expr Purif. 1998, 14: 335-342. 10.1006/prep.1998.0978. · DOI
  50. West SM, Chaudhuri JB, Howell JA: Improved protein refolding using hollow-fibre membrane dialysis. Biotechnol Bioeng. 1998, 57: 590-599. 10.1002/(SICI)1097-0290(19980305)57:5<590::AID-BIT11>3.3.CO;2-U. · DOI
  51. Yoshii H, Furuta T, Yonehara T, Ito D, Linko Y-Y, Linko P: Refolding of denatured/reduced lysozyme at high concentration with diafiltration. Biosci Biotechnol Biochem. 2000, 64: 1159-1165. · DOI
  52. Gu Z, Weidenhaupt M, Ivanova N, Pavlov M, Xu B, Su Z-G, Janson J-C: Chromatographic methods for the isolation of, and refolding of proteins from, Escherichia coli inclusion bodies. Protein Express Purif. 2002, 25: 174-179. 10.1006/prep.2002.1624. · DOI
  53. Horowitz PM, Simon D: The enzyme rhodanese can be reactivated after denaturation in guanidium chloride. J Biol Chem. 1986, 261: 13887-13891. · DOI
  54. Sørensen HP, Sperling-Petersen HU, Mortensen KK: Dialysis strategies for protein refolding: Preparative streptavidin production. Protein Express Purif. 2003, 31: 149-154. 10.1016/S1046-5928(03)00133-5. · DOI
  55. Werner MH, Clore GM, Gronenborn AM, Kondoh A, Fisher RJ: Refolding proteins by gel filtration chromatography. FEBS Lett. 1994, 345: 125-130. 10.1016/0014-5793(94)00401-3. · DOI
  56. Batas B, Chaudhuri JB: Protein refolding at high concentration using size-exclusion chromatography. Biotechnol Bioeng. 1996, 50: 16-23. 10.1002/(SICI)1097-0290(19960405)50:1<16::AID-BIT3>3.3.CO;2-Y. · DOI
  57. Batas B, Chaudhuri JB: Considerations of sample application and elution during size-exclusion chromatography-based protein refolding. J Chromatogr A. 1999, 864: 229-236. 10.1016/S0021-9673(99)01030-4. · DOI
  58. Fahey EM, Chaudhuri JB: Refolding of low molecular weight urokinase plasminogen activator by dilution and size exclusion chromatography-a comparative study. Sep Sci Technol. 2000, 35: 1743-1760. 10.1081/SS-100102491. · DOI
  59. Li M, Poliakov A, Danielson UH, Su Z, Janson JC: Refolding of a recombinant full-length non-structural (NS3) protein from hepatitis C virus by chromatographic procedures. Biotechnol Lett. 2003, 25: 1729-1734. 10.1023/A:1026050627117. · DOI
  60. Schlegl R, Iberer G, Machold C, Necina R, Jungbauer A: Continuous matrix-assisted refolding of proteins. J Chromatogr A. 2003, 1009: 119-132. 10.1016/S0021-9673(03)00432-1. · DOI
  61. Lanckriet H, Middelberg APJ: Continuous chromatographic protein refolding. J Chromatogr A. 2004, 1022: 103-113. 10.1016/j.chroma.2003.09.013. · DOI
  62. Liu H-S, Chang C-K: Chaperon solvent plug to enhance protein refolding in size exclusion chromatography. Enzyme Microb Technol. 2003, 33: 424-429. 10.1016/S0141-0229(03)00140-6. · DOI
  63. Fahey EM, Chaudhuri JB, Binding P: Refolding and purification of a urokinase plasminogen activator fragment by chromatography. J Chromatogr B. 2000, 737: 225-235. 10.1016/S0378-4347(99)00360-6. · DOI
  64. Gu Z, Zhu X, Ni S, Zhou H, Su Z: Inhibition of aggregation by media selection, sample loading and elution in size exclusion chromatographic refolding of denatured bovine carbonic anhydrase B. J Biochem Biophys Methods. 2003, 56: 165-175. 10.1016/S0165-022X(03)00057-5. · DOI
  65. Suttnar J, Dyr JE, Hamšíková E, Novák J, Vonka V: Procedure for refolding and purification of recombinant proteins from Escherichia coli inclusion bodies using a strong anion exchanger. J Chromatogr B. 1994, 656: 123-126. 10.1016/0378-4347(94)00078-6. · DOI
  66. Creighton TE: Folding of proteins adsorbed reversibly to ion-exchange resins. UCLA Symp Mol Cell Biol. 1986, 39: 249-257.
  67. Li M, Zhang G, Su Z: Dual gradient ion-exchange chromatography improved refolding yield of lysozyme. J Chromatogr A. 2002, 959: 113-120. 10.1016/S0021-9673(02)00462-4. · DOI
  68. Negro A, Onisto M, Grassato L, Caenazzo C, Garbisa S: Recombinant human TIMP-3 from Escherichia coli: Synthesis, refolding physico-chemical and functional insights. Protein Eng. 1997, 10: 593-599. 10.1093/protein/10.5.593. · DOI
  69. Zouhar J, Nanak E, Brzobohatý B: Expression, single-step purification, and matrix-assisted refolding of a maize cytokinin glucoside-specific β-glucosidase. Protein Expr Purif. 1999, 17: 153-162. 10.1006/prep.1999.1108. · DOI
  70. Rehm BHA, Qi Q, Beermann BB, Hinz H-J, Steinbüchel A: Matrix assisted in vitro refolding of Pseudomonas aeruginosa class II polyhydroxylalkanoate synthase from inclusion bodies produced in recombinant Escherichia coli. Biochem J. 2001, 358: 263-268. 10.1042/0264-6021:3580263. · DOI
  71. Stempfer G, Höll-Neugebauer B, Rudolph R: Improved refolding of an immobilized fusion protein. Nature Biotechnol. 1996, 14: 329-334. 10.1038/nbt0396-329. · DOI
  72. Cho TH, Ahn SJ, Lee EK: Refolding of protein inclusion bodies directly from E. coli homogenate using expanded bed adsorption chromatography. Bioseparation. 2001, 10: 189-96. 10.1023/A:1016305603569. · DOI
  73. Berdichevsky Y, Lamed R, Frenkel D, Gophna U, Bayer EA, Yaron S, Shoham Y, Benhar I: Matrix-assisted refolding of single-chain Fv-cellulose binding domain fusion proteins. Protein Expr Purif. 1999, 17: 249-259. 10.1006/prep.1999.1125. · DOI
  74. Geng X, Chang X: High-performance hydrophobic interaction chromatography as a tool for protein refolding. J Chromatogr A. 1992, 599: 185-194. 10.1016/0021-9673(92)85472-6. · DOI
  75. Geng X, Quan B: Mechanism of simultaneously refolding and purification of proteins by hydrophobic interaction chromatographic unit and aplications. Sci China B. 2002, 45: 655-669. 10.1360/02yb9083. · DOI
  76. Bai Q, Kong Y, Geng X: Studies on renaturation with simultaneous purification of recombinant human proinsulin from E. coli with high perfomance hydrophobic interaction chromatography. J Liq Chromatogr R T. 2003, 26: 683-695. 10.1081/JLC-120018414. · DOI
  77. Gong B, Wang L, Wang C, Geng X: Preparation of hydrophobic interaction chromatographic packings based on monodisperse poly(glycidylmethacrylate-co-ethylenedimethacrylate) beads and their application. J Chromatogr A. 2004, 1022: 33-39. 10.1016/j.chroma.2003.09.063. · DOI
  78. Wang C, Geng X, Wang D, Tian B: Purification of recombinant bovine normal prion protein PrP(104–242) by HPHIC. J Chromatogr B. 2004, 806: 185-190. 10.1016/j.jchromb.2004.03.062. · DOI
  79. Privalov PL: Physical basis of the stability of the folded conformations of proteins. In Protein folding. Edited by: Creighton TE. 1992, New York: W. H. Freeman and Company, 83-126.
  80. Robinson CR, Sligar SG: Hydrostatic and osmotic pressure as tools to study macromolecular recognition. Methods Enzymol. 1995, 259: 395-427. 10.1016/0076-6879(95)59054-4. · DOI
  81. Foguel D, Robinson CR, de Sousa PC, Silva JL, Robinson AS: Hydrostatic pressure rescues native protein from aggregates. Biotechnol Bioeng. 1999, 63: 552-558. 10.1002/(SICI)1097-0290(19990605)63:5<552::AID-BIT5>3.0.CO;2-8. · DOI
  82. St John RJ, Carpenter JF, Randolph TW: High pressure fosters protein refolding from aggregates at high concentrations. Proc Natl Acad Sci USA. 1999, 96: 13029-13033. 10.1073/pnas.96.23.13029. · DOI
  83. St John RJ, Carpenter JF, Balny C, Randolph TW: High pressure refolding of recombinant human growth hormone from insoluble aggregates: Structural transformations, kinetic barriers and energetics. J Biol Chem. 2001, 276: 46856-46863. 10.1074/jbc.M107671200. · DOI
  84. Cleland JL, Wang DIC: Cosolvent assisted protein refolding. Bio/Technology. 1990, 8: 1274-1278. 10.1038/nbt1290-1274. · DOI
  85. Goldberg ME, Expert-Bezançon N, Vuillard L, Rabilloud T: Non-detergent sulphobetaines: A new class of molecules that facilitate in vitro renaturation. Folding & Design. 1995, 1: 21-27. · DOI
  86. Vallejo LF, Brokelmann M, Marten S, Trappe S, Cabrera-Crespo J, Hoffmann A, Gross G, Weich HA, Rinas U: Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol. 2002, 94: 185-194. 10.1016/S0168-1656(01)00425-4. · DOI
  87. Kuboi R, Morita S, Ota H, Umakoshi H: Protein refolding using stimuli-responsive polymer-modified aqueous two-phase systems. J Chromatogr B. 2000, 743: 215-223. 10.1016/S0378-4347(00)00062-1. · DOI
  88. Yoshimoto N, Hashimoto T, Felix MM, Umakoshi H, Kuboi R: Artificial chaperone-assisted refolding of bovine carbonic anhydrase using molecular assemblies of stimuli-responsive polymers. Biomacromolecules. 2003, 4: 1530-1538. 10.1021/bm015662a. · DOI
  89. Arakawa T, Tsumoto K: The effects of arginine on refolding of aggregated proteins: Not facilitate refolding, but suppress aggregation. Biochem Biophys Res Commun. 2003, 304: 148-152. 10.1016/S0006-291X(03)00578-3. · DOI
  90. Tandon S, Horowitz PM: Detergent-assisted refolding of guanidium chloride-denatured rhodanese. J Biol Chem. 1987, 262: 4486-4491. · DOI
  91. Zardeneta G, Horowitz PM: Micelle-assisted protein folding. J Biol Chem. 1992, 267: 5811-5816. · DOI
  92. Yoshimoto M, Kuboi R: Oxidative refolding of denatured/reduced lysozyme utilizing the chaperone-like function of liposomes and immobilized liposome chromatography. Biotechnol Prog. 1999, 15: 480-487. 10.1021/bp990050b. · DOI
  93. Yoshimoto M, Shimanouchi T, Umakoshi H, Kuboi R: Immobilized liposome chromatography for refolding and purification of protein. J Chromatogr B. 2000, 743: 93-99. 10.1016/S0378-4347(00)00051-7. · DOI
  94. Zardeneta G, Horowitz PM: Detergent, liposome, and micelle-assisted protein refolding. Anal Biochem. 1994, 223: 1-6. 10.1006/abio.1994.1537. · DOI
  95. Zardeneta G, Horowitz PM: Protein refolding at high concentrations using detergent/phospholipid mixtures. Anal Biochem. 1994, 218: 392-398. 10.1006/abio.1994.1197. · DOI
  96. Hagen AJ, Hatton TA, Wang DIC: Protein refolding in reversed micelles. Biotechnol Bioeng. 1990, 35: 955-965. · DOI
  97. Hashimoto Y, Ono T, Goto M, Hatton TA: Protein refolding by reversed micelles utilizing solid-liquid extraction technique. Biotechnol Bioeng. 1998, 57: 620-623. 10.1002/(SICI)1097-0290(19980305)57:5<620::AID-BIT14>3.3.CO;2-4. · DOI
  98. Goto M, Hashimoto Y, Fujita T-A, Ono T, Furusaki S: Important parameters affecting efficiency of protein refolding by reversed micelles. Biotechnol Prog. 2000, 16: 1079-1085. 10.1021/bp000073m. · DOI
  99. Vinogradov AA, Kudryashova EV, Levashov AV, van Dongen WMAM: Solubilization and refolding of inclusion body proteins in reverse micelles. Anal Biochem. 2003, 320: 234-238. 10.1016/S0003-2697(03)00384-1. · DOI
  100. Ewalt KL, Hendrick JP, Houry WA, Hartl FU: In vivo observation of polypeptide flux through the bacterial chaperonin system. Cell. 1997, 90: 491-500. 10.1016/S0092-8674(00)80509-7. · DOI
  101. Hartl FU: Molecular chaperones in cellular protein folding. Nature. 1996, 381: 571-580. 10.1038/381571a0. · DOI
  102. Thomas JG, Ayling A, Baneyx F: Molecular chaperones, folding catalysts, and the recoverey of active recombinant proteins from E. coli. Appl Biochem Biotechnol. 1997, 66: 197-238. · DOI
  103. Buchner J, Brinkmann U, Pastan I: Renaturation of a single-chain immunotoxin facilitated by chaperones and protein disulfide isomerase. Bio/Technology. 1992, 10: 682-685. 10.1038/nbt0692-682. · DOI
  104. Altamirano MM, Golbik R, Zahn R, Buckle AM, Fersht AR: Refolding chromatography with immobilized mini-chaperones. Proc Natl Acad Sci USA. 1997, 94: 3576-3578. 10.1073/pnas.94.8.3576. · DOI
  105. Gao Y-G, Guan Y-X, Yao S-J, Cho M-G: On-column refolding of recombinant human interferon-γ with an immobilized chaperone fragment. Biotechnol Prog. 2003, 19: 915-920. 10.1021/bp025775l. · DOI
  106. Rozema D, Gellman SH: Artificial chaperones: Protein refolding via sequential use of detergent and cyclodextrin. J Am Chem Soc. 1995, 117: 2373-2374. · DOI
  107. Rozema D, Gellman SH: Artificial chaperone-assisted refolding of carbonic anhydrase B*. J Biol Chem. 1996, 271: 3478-3487. 10.1074/jbc.271.7.3478. · DOI
  108. Rozema D, Gellman SH: Artificial chaperone-assisted refolding of denatured-reduced lysozyme: Modulation of the competition between renaturation and aggregation. Biochemistry. 1996, 35: 15760-15771. 10.1021/bi961638j. · DOI
  109. Nath D, Rao M: Arificial chaperone mediated refolding of xylanase from an alkalopholic thermophlic Bacillus sp. Eur J Biochem. 2001, 268: 5471-5478. 10.1046/j.0014-2956.2001.02485.x. · DOI
  110. Nomura Y, Ikeda M, Yamaguchi N, Aoyama Y, Akiyoshi K: Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone. FEBS Lett. 2003, 553: 271-276. 10.1016/S0014-5793(03)01028-7. · DOI
  111. Daugherty DL, Rozema D, Hanson PE, Gellman SH: Artificial chaperone-assisted refolding of citrate synthase. J Biol Chem. 1998, 273: 33961-33971. 10.1074/jbc.273.51.33961. · DOI
  112. Machida S, Ogawa S, Xiaohua S, Takaha T, Fujii K, Hayashi K: Cycloamylose as an efficient artificial chaperone for protein refolding. FEBS Lett. 2000, 486: 131-135. 10.1016/S0014-5793(00)02258-4. · DOI
  113. Mannen T, Yamaguchi S, Honda J, Sugimoto S, Nagamune T: Expanded-bed protein refolding using a solid-phase artificial chaperone. J Biosci Bioeng. 2001, 91: 403-408. 10.1263/jbb.91.403. · DOI
  114. Simon SM, Peskin CS, Oster GF: What drives the translocations of proteins. Proc Natl Acad Sci USA. 1992, 89: 3770-3774. · DOI
  115. Yoshii H, Furuta T, Yasunishi A, Kojima T: Rapid renaturation of denatured and aggregated proteins using liquid paraffin as a pseudolipid bilayer membrane. Biotechnol Bioeng. 1994, 43: 57-63. · DOI
  116. Shinde U, Inouye M: Intramolecular chaperones and protein folding. Trends Biochem Sci. 1993, 18: 442-446. 10.1016/0968-0004(93)90146-E. · DOI
  117. Beer H-D, Wohlfahrt G, Schmid RD, McCarthy JEG: The folding and activity of the extracellular lipase of Rhizopus oryzae are modulated by a prosequence. Biochem J. 1996, 319: 351-359. · DOI
  118. Tang B, Nirasawa S, Kitaoka M, Marie-Claire C, Hayashi K: General function of N-terminal propeptide on assisting protein folding and inhibiting catalytic activity based on observations with a chimeric thermolysin-like protease. Biochem Biophys Res Commun. 2003, 301: 1093-1098. 10.1016/S0006-291X(03)00084-6. · DOI
  119. Rattenholl A, Lilie H, Grossmann A, Stern A, Schwarz E, Rudolph R: The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. Eur J Biochem. 2001, 268: 3296-3303. 10.1046/j.1432-1327.2001.02232.x. · DOI
  120. Jin H-J, Dunn MA, Borthakur D, Kim YS: Refolding and purification of unprocessed porcine myostatin expressed in Escherichia coli. Protein Expr Purif. 2004, 35: 1-10. 10.1016/j.pep.2004.01.001. · DOI
  121. Hahm MS, Chung BH: Refolding and purification of yeast carboxypeptidase Y expressed as inclusion bodies in Escherichia coli. Protein Expr Purif. 2001, 22: 101-107. 10.1006/prep.2001.1418. · DOI
  122. Ermolenko DN, Zherdev AV, Dzantiev BB, Popov VO: Antiperoxidase antibodies enhance refolding of horseradish peroxidase. Biochem Biophys Res Commun. 2002, 291: 959-965. 10.1006/bbrc.2002.6544. · DOI
  123. Xu Q, Xie Z, Ding J, Lin S-X, Xu G: Monoclonal antibodies assisting refolding of firefly luciferase. Protein Sci. 2004, 13: 1851-1858. 10.1110/ps.04699904. · DOI
  124. Ahmed AK, Schaffer SW, Wetlaufer DB: Nonenzymic reactivation of reduced bovine pancreatic ribonuclease by air oxidation and by glutathione oxidoreduction buffers. J Biol Chem. 1975, 250: 8477-8482. · DOI
  125. Menzella HG, Gramajo HC, Ceccarelli EA: High recovery of prochymosin from inclusion bodies using controlled air oxidation. Protein Express Purif. 2002, 25: 248-255. 10.1016/S1046-5928(02)00006-2. · DOI
  126. Rudolph R, Lilie H: In vitro folding of inclusion body proteins. FASEB J. 1996, 10: 49-56. · DOI
  127. Wetlaufer DB, Branca PA, Chen G-X: The oxidative folding of proteins by disulfide plus thiol does not correlate with redox potential. Protein Eng. 1987, 1: 141-146. · DOI
  128. Misawa S, Kumagai I: Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies. Biopolymers. 1999, 51: 297-307. 10.1002/(SICI)1097-0282(1999)51:4<297::AID-BIP5>3.0.CO;2-I. · DOI
  129. DeCollo TV, Lees WJ: Effects of aromatic thiols on thiol-disulfide interchange reactions that occur during protein folding. J Org Chem. 2001, 66: 4244-4249. 10.1021/jo015600a. · DOI
  130. Gough JD, Williams RH, Donofrio AE, Lees WJ: Folding disulfide-containing proteins faster with an aromatic thiol. J Am Chem Soc. 2002, 124: 3885-3892. 10.1021/ja016938p. · DOI
  131. Shimizu H, Fujimoto K, Kawaguchi H: Refolding of protein using thiol-carrying latex particles. Colloid Surface A. 1999, 153: 421-427. 10.1016/S0927-7757(98)00625-6. · DOI
  132. Shimizu H, Fujimoto K, Kawaguchi H: Renaturation of reduced ribonuclease A with a microsphere-induced refolding system. Biotechnol Prog. 2000, 16: 248-253. 10.1021/bp000008c. · DOI
  133. Kuhelj R, Dolinar M, Pungercar J, Turk V: The preparation of cataytically active cathepsin B from its precursor expressed in Escherichia coli in the form of inclusion bodies. Eur J Biochem. 1995, 229: 533-539. · DOI
  134. Mukhopadhyay A: Reversible protection of disulfide bonds followed by oxidative folding render recombinant hCGβ highly immunogenic. Vaccine. 2000, 18: 1802-1810. 10.1016/S0264-410X(99)00482-X. · DOI
  135. Rudolph R: Renaturation of recombinant, disulfide-bonded proteins from "inclusion bodies". In Modern methods in protein and nucleic acid analysis. Edited by: Tschesche H. 1990, Berlin New York: Walter de Gruyter, 149-171.
  136. Gilbert HF: Protein disulfide isomerase and assisted protein folding. J Biol Chem. 1997, 272: 29399-29402. 10.1074/jbc.272.47.29399. · DOI
  137. Lilie H, McLaughlin S, Freedman R, Buchner J: Influence of protein disulfide isomerase (PDI) on antibody folding in vitro. J Biol Chem. 1994, 269: 14290-14296. · DOI
  138. Shin H-C, Scheraga HA: Catalysis of the oxidative folding of bovine pancreatic ribonuclease A by protein disulfide isomerase. J Mol Biol. 2000, 300: 995-1003. 10.1006/jmbi.2000.3928. · DOI
  139. Singh RR, Rao AGA: Reductive unfolding and oxidative refolding of a Bowman-Birk inhibitor from horsegram seeds (Dolichos biflorus): Evidence for 'hyperreactive' disulfide bonds and rate-limiting nature of disulfide isomerization in folding. Biochim Biophys Acta. 2002, 1597: 280-291. 10.1016/S0167-4838(02)00301-1. · DOI
  140. Hawkins HC, Freedman RB: The effect of denaturants on PDI conformation and activity. Biochem Soc Trans. 1995, 23: 65S- · DOI
  141. Cabrele C, Fiori S, Pegoraro S, Moroder L: Redox-active cyclic bis(cysteinyl)peptides as catalysts for in vitro oxidative protein folding. Chem Biol. 2002, 9: 731-740. 10.1016/S1074-5521(02)00152-7. · DOI
  142. Woycechowsky KJ, Wittrup KD, Raines RT: A small-molecule catalyst of protein folding in vitro and in vivo. Chem Biol. 1999, 6: 871-879. 10.1016/S1074-5521(00)80006-X. · DOI
  143. Woycechowsky KJ, Hook BA, Raines RT: Catalysis of protein folding by an immobilized small-molecule dithiol. Biotechnol Prog. 2003, 19: 1307-1314. 10.1021/bp0257123. · DOI
  144. Winter J, Lilie H, Rudolph R: Recombinant expression and in vitro folding of proinsulin are stimulated by the synthetic dithiol Vectrase-P. FEMS Microbiol Lett. 2002, 213: 225-230. 10.1016/S0378-1097(02)00819-4. · DOI
  145. Hart RA, Lester PM, Reifsnyder DH, Ogez JR, Builder SE: Large scale, in situ isolation of periplasmic IGF-I from E. coli. Bio/Technology. 1994, 12: 1113-1116. 10.1038/nbt1194-1113. · DOI
  146. Falconer RJ, O'Neill BK, Middelberg APJ: Chemical treatment of Escherichia coli: 3. Selective extraction of a recombinant protein from cytoplasmic inclusion bodies in intact cells. Biotechnol Bioeng. 1999, 62: 455-460. 10.1002/(SICI)1097-0290(19990220)62:4<455::AID-BIT8>3.0.CO;2-2. · DOI
  147. Choe W-S, Clemmitt RH, Chase HA, Middelberg APJ: Coupling of chemical extraction and expanded-bed adsorption for simplified inclusion-body processing: Optimization using surface plasmon resonance. Biotechnol Bioeng. 2003, 81: 221-232. 10.1002/bit.10471. · DOI
  148. Choe W, Clemmitt R, Rito-Palomares M, Chase HA, Middelberg APJ: Bioprocess intensification: A radical new process for recovering inclusion body protein. Trans IChemE. 2002, 80: 45-50. 10.1205/096030802753479106. · DOI
  149. Choe W-S, Clemmitt RH, Chase HA, Middelberg APJ: Comparison of histidine-tag capture chemistries for purification following chemical extraction. J Chromatogr A. 2002, 953: 111-121. 10.1016/S0021-9673(02)00154-1. · DOI
  150. Heeboll-Nielsen A, Choe W-S, Middelberg APJ, Thomas ORT: Efficient inclusion body processing using chemical extraction and high gradient magnetic fishing. Biotechnol Prog. 2003, 19: 887-898. 10.1021/bp025553n. · DOI
  151. Lee CT, Morreale G, Middelberg APJ: Combined in-fermenter extraction and cross-flow microfiltration for improved inclusion body processing. Biotechnol Bioeng. 2004, 85: 103-113. 10.1002/bit.10878. · DOI
  152. Ahn JH, Lee YP, Rhee JS: Investigation of refolding condition for Pseudomonas fluorescens lipase by response surface methodology. J Biotechnol. 1997, 54: 151-160. 10.1016/S0168-1656(97)01693-3. · DOI
  153. Lu H, Zhang H, Wang Q, Yuan H, He W, Zhao Z, Li Y: Purification, refolding of hybrid hIFNγ-kringle 5 expressed in Escherichia coli. Curr Microbiol. 2001, 42: 211-216. 10.1007/s002840010206. · DOI
  154. Ho JGS, Middelberg APJ: Estimating the potential refolding yield of recombinant proteins expressed as inclusion boidies. Biotechnol Bioeng. 2004, 87: 584-592. 10.1002/bit.20148. · DOI
  155. Trésaugues L, Collinet B, Minard P, Henckes G, Aufrère R, Blondeau K, Liger D, Zhou C-Z, Janin J, van Tilbeurgh H, Quevillon-Cheruel S: Refolding strategies from inclusion bodies in a structural genomics project. J Struct Funct Genomics. 2004, 5: 195-204. 10.1023/B:JSFG.0000029017.46332.e3. · DOI

Cited by

Sorted by citations

Metadata

Authors
Vallejo, L. F., & Rinas, U.
Venue
Microbial Cell Factories
Published
2004-09-02
Volume
3
Issue
1
ISSN
1475-2859
Cited by
311
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review